| 
			
			 "The UK is not to blame. The EU is not to blame," said an EU 
			official. "It's about everyone finding agreement with a company that 
			has been over-selling its production capacity. AstraZeneca has to 
			deliver doses to its EU customers." 
 After falling far behind post-Brexit Britain and the United States 
			in rolling out vaccines, the EU's leaders are due to discuss 
			imposing a ban on vaccine exports to Britain at a summit on 
			Thursday.
 
 British Prime Minister Boris Johnson is expected to speak to the 
			EU's most powerful leaders, German Chancellor Angela Merkel and 
			French President Emmanuel Macron, in a bid to get the bloc to steer 
			away from bans.
 
			 
			
 "There will continue to be some robust conversations with the 
			European Union about the importance of no such blockings happening," 
			Helen Whately, a junior health minister, told LBC radio. "It's 
			really important that companies are able to fulfil their contractual 
			obligations."
 
 Britain, which exited the EU's orbit on Dec. 31, has repeatedly 
			cautioned the EU that breaking contract law could have grave 
			consequences but has not yet specified what those consequences would 
			be.
 
 AstraZeneca has told Brussels that the UK is using a clause in its 
			supply contract that prevents exports of its vaccines until the 
			British market is fully served, EU officials said.
 
 While France, Germany and Italy broadly support tighter export curbs 
			on those who do not reciprocate, countries including the 
			Netherlands, Belgium and Ireland are more cautious about cutting off 
			the UK.
 
			
            [to top of second column] | 
			
			 The EU has so far blocked one 
								shipment of vaccines to Australia.
 An EU official told Reuters on Sunday that the 
								bloc was rebuffing British government calls to 
								ship AstraZeneca COVID-19 vaccines produced in a 
								factory in the Netherlands.
 
 "The Brits are insisting that the Halix plant in 
								the Netherlands must deliver the drug substance 
								produced there to them. That doesn't work," the 
								official told Reuters.
 The 
			Leiden-based plant, run by sub-contractor Halix, is listed as a 
			supplier of vaccines in both the contracts that AstraZeneca has 
			signed with Britain and with the European Union.
 "What is produced in Halix has to go to the EU," the official added.
 
 AstraZeneca has not yet sought approval in the EU for Halix, but the 
			official and a second EU source said the request was on its way. 
			Without regulatory approval, vaccines produced at Halix cannot be 
			used in the EU.
 
 As of March 20, the UK had administered nearly 44 vaccines for every 
			100 people, whereas the EU had administered nearly 13 shots per 100 
			people, according to public data compiled by Our World In Data 
			website.
 
 (Reporting by Paul Sandle in Londion and John Chalmers in Brussels; 
			Additional reporting by Sarah Young in London; Writing by Guy 
			Faulconbridge; Editing by Nick Macfie)
 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content   |